Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel: +47 21 07 81 60
E-mail:

Copyright/Disclaimer

New DDDs

ATC code	ATC level name	New DDD	Unit	Adm.route
N06BA14	solriamfetol	0.1	g	O
L04AJ07	crovalimab	24.3	mg	P
L04AE05	etrasimod	2	mg	O
L04AE03	siponimod	2	mg	O
L03AC03	nogapendekin alfa and inbakicept	12.5	mcg	intravesical
L02BX04	relugolix	0.12	g	O
L01XX52	venetoclax	0.4	g	O
L01XX44	aflibercept	20	mg	P
L01XX27	arsenic trioxide	7.5	mg	P
L01XX05	hydroxycarbamide	1.4	g	O
L01XK03	rucaparib	1.2	g	O
L01XK02	niraparib	0.3	g	O
L01XK01	olaparib	0.6	g	O
L01XJ02	sonidegib	0.2	g	O
L01XJ01	vismodegib	0.15	g	O
L01XG03	ixazomib	0.43	mg	O
L01XB01	procarbazine	0.1	g	O
L01FX08	elotuzumab	50	mg	P
L01FX07	blinatumomab	18.7	mcg	P
L01FX05	brentuximab vedotin	6	mg	P
L01FX04	ipilimumab	10	mg	P
L01FG02	ramucirumab	40	mg	P
L01FF06	cemiplimab	16.7	mg	P
L01FF05	atezolizumab	57.1 ⁴⁾	mg	P
L01FF04	avelumab	57.1	mg	P
L01FF03	durvalumab	53.6	mg	P
L01FF02	pembrolizumab	9.5	mg	P
L01FF01	nivolumab	17.1	mg	P
L01FD04	trastuzumab deruxtecan	18	mg	P
L01FD03	trastuzumab emtansine	12	mg	P
L01FD02	pertuzumab	20	mg	P
L01FD01	trastuzumab	28.6 ³⁾	mg	P
L01FC01	daratumumab	64.3 ³⁾	mg	P
L01FA03	obinutuzumab	35.7	mg	P
L01EX27	capivasertib	0.46	g	O
L01EM06	inavolisib	9	mg	O
L01EL05	pirtobrutinib	0.2	g	O
L01EK04	fruquintinib	3.75	mg	O
L01EJ04	momelotinib	0.2	g	O
L01EB12	firmonertinib	80	mg	O
L01BB04	cladribine	6.3 ²⁾	mg	P
L01AX04	dacarbazine	43.3	mg	P
J01DF51	aztreonam and beta-lactamase inhibitor	6 ¹⁾	g	P
D11AH10	lebrikizumab	8.9	mg	P
C09XX01	sparsentan	0.4	g	O
C01EB22	meldonium	0.75	g	O
B03XA10	efepoetin alfa	20	mcg	P
B01AD13	apadamtase alfa and cinaxadamtase alfa	200	U	P
A16AX19	fosdenopterin	63	mg	P

1) refers to aztreonam
2) Refers to IV infusion
3) Refers to SC injection
4) Refers to IV infusion

Last updated: 2025-12-15